Literature DB >> 10623743

Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.

K Das1, J Bohl, S B Vande Pol.   

Abstract

Papillomavirus E6 oncoproteins transform mammalian cells through interaction with cellular proteins. Bovine papillomavirus type 1 E6 (BE6) interacts with three previously described cellular targets: the E6AP E3 ubiquitin ligase, the calcium-binding protein E6BP (also known as ERC-55), and paxillin, which is a focal adhesion adapter protein. BE6 interacts strongly with each of these proteins in vitro, binding to similar peptide sequences found in E6AP, E6BP, and paxillin. To determine which BE6 interactions are necessary for transformation by BE6, we used a novel selection strategy for temperature-sensitive BE6 mutants in yeast that could discriminate in their interaction between E6AP, E6BP, and paxillin. All BE6 mutants that retained transforming ability retained association with paxillin, while some mutants that were transformation positive failed to interact with E6AP or E6BP. This study demonstrates that oncogene mutants that are temperature sensitive for transformation can be selected in yeast and that the induction of anchorage-independent cell proliferation by BE6 does not require strong association of BE6 with either E6AP or E6BP. Of particular interest is the identification of a BE6 mutant that interacts strongly with the acidic charged leucine motifs of E6AP, E6BP, and paxillin but is devoid of transformation activity, thereby genetically identifying a second essential transformation function in BE6 that is independent of interaction with acidic charged leucine motifs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623743      PMCID: PMC111601          DOI: 10.1128/jvi.74.2.812-816.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

Review 1.  Paxillin LD motifs may define a new family of protein recognition domains.

Authors:  M C Brown; M S Curtis; C E Turner
Journal:  Nat Struct Biol       Date:  1998-08

2.  E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box.

Authors:  C Kühne; L Banks
Journal:  J Biol Chem       Date:  1998-12-18       Impact factor: 5.157

3.  Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.

Authors:  R Ned; S Allen; S Vande Pol
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.

Authors:  S B Vande Pol; M C Brown; C E Turner
Journal:  Oncogene       Date:  1998-01-08       Impact factor: 9.867

5.  Identification of an alpha helical motif sufficient for association with papillomavirus E6.

Authors:  J J Chen; Y Hong; E Rustamzadeh; J D Baleja; E J Androphy
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

6.  The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase.

Authors:  X Tong; R Salgia; J L Li; J D Griffin; P M Howley
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

7.  Human papillomavirus oncoprotein E6 binds to the C-terminal region of human minichromosome maintenance 7 protein.

Authors:  I Kukimoto; S Aihara; K Yoshiike; T Kanda
Journal:  Biochem Biophys Res Commun       Date:  1998-08-10       Impact factor: 3.575

8.  The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.

Authors:  Q Gao; S Srinivasan; S N Boyer; D E Wazer; V Band
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

9.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.

Authors:  J J Chen; C E Reid; V Band; E J Androphy
Journal:  Science       Date:  1995-07-28       Impact factor: 47.728

View more
  12 in total

1.  Loss of the EP2 prostaglandin E2 receptor in immortalized human keratinocytes results in increased invasiveness and decreased paxillin expression.

Authors:  Raymond L Konger; Glynis A Scott; Yvonne Landt; Jack H Ladenson; Alice P Pentland
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.

Authors:  Choongho Lee; Laimonis A Laimins
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 3.  Papillomavirus E6 oncoproteins.

Authors:  Scott B Vande Pol; Aloysius J Klingelhutz
Journal:  Virology       Date:  2013-05-24       Impact factor: 3.616

4.  Overexpression of Paxillin Correlates with Tumor Progression and Predicts Poor Survival in Glioblastoma.

Authors:  Li-Hua Sun; Fu-Qiang Yang; Chuan-Bao Zhang; Yi-Ping Wu; Jing-Shan Liang; Shuai Jin; Zheng Wang; Hong-Jun Wang; Zhao-Shi Bao; Zheng-Xiang Yang; Tao Jiang
Journal:  CNS Neurosci Ther       Date:  2016-09-17       Impact factor: 5.243

5.  Transformation by bovine papillomavirus type 1 E6 requires paxillin.

Authors:  Ramon Wade; Nicole Brimer; Scott Vande Pol
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

6.  Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein.

Authors:  Yi Zhang; Jhimli Dasgupta; Runlin Z Ma; Lawrence Banks; Miranda Thomas; Xiaojiang S Chen
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Strategies for bacterial expression of protein-peptide complexes: application to solubilization of papillomavirus E6.

Authors:  Abdellahi Ould M'hamed Ould Sidi; Khaled Ould Babah; Nicole Brimer; Yves Nominé; Christophe Romier; Bruno Kieffer; Scott Vande Pol; Gilles Travé; Katia Zanier
Journal:  Protein Expr Purif       Date:  2011-07-14       Impact factor: 1.650

8.  Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.

Authors:  Katia Zanier; Sebastian Charbonnier; Abdellahi Ould M'hamed Ould Sidi; Alastair G McEwen; Maria Giovanna Ferrario; Pierre Poussin-Courmontagne; Vincent Cura; Nicole Brimer; Khaled Ould Babah; Tina Ansari; Isabelle Muller; Roland H Stote; Jean Cavarelli; Scott Vande Pol; Gilles Travé
Journal:  Science       Date:  2013-02-08       Impact factor: 47.728

9.  Cutaneous papillomavirus E6 oncoproteins associate with MAML1 to repress transactivation and NOTCH signaling.

Authors:  N Brimer; C Lyons; A E Wallberg; S B Vande Pol
Journal:  Oncogene       Date:  2012-01-16       Impact factor: 9.867

10.  Bovine papillomavirus E5 and E7 oncoproteins in naturally occurring tumors: are two better than one?

Authors:  Annunziata Corteggio; Gennaro Altamura; Franco Roperto; Giuseppe Borzacchiello
Journal:  Infect Agent Cancer       Date:  2013-01-09       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.